Maxim Group Downgrades Aytu BioPharma to Hold
Maxim Group analyst Naz Rahman downgrades Aytu BioPharma (NASDAQ:AYTU) from Buy to Hold.
Follow the latest AYTU BioPharma, Inc. (AYTU) news and market headlines alongside the live AYTU price. Stay informed on what's moving AYTU.
Maxim Group analyst Naz Rahman downgrades Aytu BioPharma (NASDAQ:AYTU) from Buy to Hold.
Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) shares rose 169.8% to $20.16 during Tuesday's regular session. The market value of their outstanding shares is at $1.5 billion. As per the press release, Q3 earnings
Gainers Aytu BioPharma (NASDAQ:AYTU) shares rose 45.0% to $2.64 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.7 million. The company's, Q1 earnings came out
Aytu Biopharma surged 42.9% after strong revenue and a proposed Rosemont acquisition; Cloudastructure led gainers, while Bridger Aerospace and Stem fell.
Aytu BioPharma shares surged after hours as investors assessed results and acquisition terms.
Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.26) by 23.08 percent. This is a 150 percent decrease over losses of $(0.08) per share from the
Agreement with Rosemont Pharmaceuticals provides for all-cash consideration of $2.70 per shareTender offer price represents 41.1% premium to 30-day volume-weighted average price and 51.7% premium to the closing price on
Zealand Pharma A/S reported a quarterly loss of $0.12 per share, beating consensus estimates of $1.33 loss by 90.98%, but revenues of $0.62 million missed estimates by 97.57%. The stock has declined 48.7% year-to-date versus the S&P 500's 11.3% gain. The company holds a Zacks Rank #3 (Hold) rating with mixed estimate revisions.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to AYTU, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.